Antares Pharma Profit Margin

The latest profit margin for ATRS is 21.9% as of March 2022. That compares with 39.31% in the prior-year period — down 44.3% year over year. That is above the Healthcare sector average of 14.34%. Investors often review this figure alongside Antares Pharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, ATRS's profit margin moved from 39.31% to 21.9% — a 44.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Antares Pharma's valuation or profitability profile.

Against Healthcare companies, ATRS currently prints 21.9% for profit margin, while the sector average sits near 14.34%. That is roughly 52.7% above the sector mean. Large gaps often invite a closer look at Antares Pharma's growth, margins, and balance sheet.

Profit Margin shows how effectively Antares Pharma converts resources into returns. At 21.9%, ATRS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 39.31% in the prior-year period — down 44.3% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ATRS's profit margin (21.9%), review year-over-year change from 39.31%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.